Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 38.31 as of 2026-09-14T12:20:21.375Z.
Consensus retrieved: 2026-09-13T22:20:21.985Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-09-14T12:20:21.375Z.
Quote observation: 2026-09-11T20:00:02.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 05165740158cec8c3f7564cbf5b405835acb2fde45df6a838603a5f0772893f5
Forward PE Ratio (38.31) = Dated Quote Price ($369.32) / Consensus Forward EPS ($9.64)
FORWARD PE RATIO
38.31
SECTOR MEDIAN · HEALTHCARE
18.99
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+101.74%
vs the sector median at left
Bio-Rad Laboratories, Inc.
Market Cap
$9.94B
Forward PE Ratio
38.31
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Bio-Rad Laboratories, Inc. (BIO) | $9.94B | 38.31 |
| Globus Medical, Inc. (GMED)vs › | $10.01B | 14.84 |
| Henry Schein, Inc. (HSIC)vs › | $10.07B | 16.41 |
| The Ensign Group, Inc. (ENSG)vs › | $10.14B | 22.32 |
| Tempus AI, Inc. (TEM)vs › | $10.34B | N/A |
| The Cooper Companies, Inc. (COO)vs › | $10.51B | 11.87 |
| Universal Health Services, Inc. (UHS)vs › | $10.58B | 7.76 |
| Molina Healthcare, Inc. (MOH)vs › | $10.66B | N/A |
| Insulet Corp. (PODD)vs › | $9.14B | 20.29 |
| Align Technology, Inc. (ALGN)vs › | $10.80B | 13.36 |
Trailing P/E
44.8
reported TTM EPS
Forward P/E
38.3
consensus EPS · fiscal year ending 2026-12-31
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $9.64 implies +16.8% EPS growth vs the reported trailing $8.25.
At the dated quote price of $369.32, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $9.64 | $9.19 – $10.09 | 2 | 38.3x |
| 2027-12-31 | $10.35 | $10.18 – $10.50 | 2 | 35.7x |
| 2028-12-31 | $11.23 | $10.88 – $11.41 | 1 | 32.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
